Cargando…

Measuring research impact: a large cancer research funding programme in Australia

BACKGROUND: Measuring research impact is of critical interest to philanthropic and government funding agencies interested in ensuring that the research they fund is both scientifically excellent and has meaningful impact into health and other outcomes. The Beat Cancer Project (BCP) is a AUD $34 m ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Bowden, Jacqueline A., Sargent, Nicole, Wesselingh, Steve, Size, Lincoln, Donovan, Claire, Miller, Caroline L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944042/
https://www.ncbi.nlm.nih.gov/pubmed/29743088
http://dx.doi.org/10.1186/s12961-018-0311-3
_version_ 1783321747327549440
author Bowden, Jacqueline A.
Sargent, Nicole
Wesselingh, Steve
Size, Lincoln
Donovan, Claire
Miller, Caroline L.
author_facet Bowden, Jacqueline A.
Sargent, Nicole
Wesselingh, Steve
Size, Lincoln
Donovan, Claire
Miller, Caroline L.
author_sort Bowden, Jacqueline A.
collection PubMed
description BACKGROUND: Measuring research impact is of critical interest to philanthropic and government funding agencies interested in ensuring that the research they fund is both scientifically excellent and has meaningful impact into health and other outcomes. The Beat Cancer Project (BCP) is a AUD $34 m cancer research funding scheme that commenced in 2011. It was initiated by an Australian charity (Cancer Council SA), and supported by the South Australian Government and the state’s major universities. METHODS: This study applied Buxton and Hanney’s Payback Framework to assess research impact generated from the BCP after 3 years of funding. Data sources were an audit of peer-reviewed publications from January 2011 to September 2014 from Web of Knowledge and a self-report survey of investigators awarded BCP research funding during its first 3 years of implementation (2011–2013). Of the 104 surveys, 92 (88%) were completed. RESULTS: The BCP performed well across all five categories of the Payback Framework. In terms of knowledge production, 1257 peer-reviewed publications were generated and the mean impact factor of publishing journals increased annually. There were many benefits to future research with 21 respondents (23%) reporting career advancement, and 110 higher degrees obtained or expected (including 84 PhDs). Overall, 52% of funded projects generated tools for future research. The funded research attracted substantial further income yielding a very high rate of leverage. For every AUD $1 that the cancer charity invested, the BCP gained an additional AUD $6.06. Five projects (5%) had informed policy and 5 (5%) informed product development, with an additional 31 (34%) and 35 (38%) projects, respectively, anticipating doing so. In terms of health and sector and broader economic benefits, 8 (9%) projects had influenced practice or behaviour of health staff and 32 (34%) would reportedly to do so in the future. CONCLUSIONS: Research impact was a priority of charity and government funders and led to a deliberate funding strategy. Emphasising research impact while maintaining rigorous, competitive processes can achieve the joint objectives of excellence in research, yielding good research impact and a high rate of leverage for philanthropic and public investment, as indicated by these early results. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12961-018-0311-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5944042
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59440422018-05-14 Measuring research impact: a large cancer research funding programme in Australia Bowden, Jacqueline A. Sargent, Nicole Wesselingh, Steve Size, Lincoln Donovan, Claire Miller, Caroline L. Health Res Policy Syst Research BACKGROUND: Measuring research impact is of critical interest to philanthropic and government funding agencies interested in ensuring that the research they fund is both scientifically excellent and has meaningful impact into health and other outcomes. The Beat Cancer Project (BCP) is a AUD $34 m cancer research funding scheme that commenced in 2011. It was initiated by an Australian charity (Cancer Council SA), and supported by the South Australian Government and the state’s major universities. METHODS: This study applied Buxton and Hanney’s Payback Framework to assess research impact generated from the BCP after 3 years of funding. Data sources were an audit of peer-reviewed publications from January 2011 to September 2014 from Web of Knowledge and a self-report survey of investigators awarded BCP research funding during its first 3 years of implementation (2011–2013). Of the 104 surveys, 92 (88%) were completed. RESULTS: The BCP performed well across all five categories of the Payback Framework. In terms of knowledge production, 1257 peer-reviewed publications were generated and the mean impact factor of publishing journals increased annually. There were many benefits to future research with 21 respondents (23%) reporting career advancement, and 110 higher degrees obtained or expected (including 84 PhDs). Overall, 52% of funded projects generated tools for future research. The funded research attracted substantial further income yielding a very high rate of leverage. For every AUD $1 that the cancer charity invested, the BCP gained an additional AUD $6.06. Five projects (5%) had informed policy and 5 (5%) informed product development, with an additional 31 (34%) and 35 (38%) projects, respectively, anticipating doing so. In terms of health and sector and broader economic benefits, 8 (9%) projects had influenced practice or behaviour of health staff and 32 (34%) would reportedly to do so in the future. CONCLUSIONS: Research impact was a priority of charity and government funders and led to a deliberate funding strategy. Emphasising research impact while maintaining rigorous, competitive processes can achieve the joint objectives of excellence in research, yielding good research impact and a high rate of leverage for philanthropic and public investment, as indicated by these early results. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12961-018-0311-3) contains supplementary material, which is available to authorized users. BioMed Central 2018-05-09 /pmc/articles/PMC5944042/ /pubmed/29743088 http://dx.doi.org/10.1186/s12961-018-0311-3 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Bowden, Jacqueline A.
Sargent, Nicole
Wesselingh, Steve
Size, Lincoln
Donovan, Claire
Miller, Caroline L.
Measuring research impact: a large cancer research funding programme in Australia
title Measuring research impact: a large cancer research funding programme in Australia
title_full Measuring research impact: a large cancer research funding programme in Australia
title_fullStr Measuring research impact: a large cancer research funding programme in Australia
title_full_unstemmed Measuring research impact: a large cancer research funding programme in Australia
title_short Measuring research impact: a large cancer research funding programme in Australia
title_sort measuring research impact: a large cancer research funding programme in australia
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944042/
https://www.ncbi.nlm.nih.gov/pubmed/29743088
http://dx.doi.org/10.1186/s12961-018-0311-3
work_keys_str_mv AT bowdenjacquelinea measuringresearchimpactalargecancerresearchfundingprogrammeinaustralia
AT sargentnicole measuringresearchimpactalargecancerresearchfundingprogrammeinaustralia
AT wesselinghsteve measuringresearchimpactalargecancerresearchfundingprogrammeinaustralia
AT sizelincoln measuringresearchimpactalargecancerresearchfundingprogrammeinaustralia
AT donovanclaire measuringresearchimpactalargecancerresearchfundingprogrammeinaustralia
AT millercarolinel measuringresearchimpactalargecancerresearchfundingprogrammeinaustralia